Cite
Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease
MLA
Chi Zhang, et al. “Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease.” International Journal of Molecular Sciences, vol. 24, no. 15, Aug. 2023, p. 12328. EBSCOhost, https://doi.org/10.3390/ijms241512328.
APA
Chi Zhang, Huihui Shao, Zunsheng Han, Bo Liu, Jing Feng, Jie Zhang, Wenxuan Zhang, Kun Zhang, Qingyun Yang, & Song Wu. (2023). Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease. International Journal of Molecular Sciences, 24(15), 12328. https://doi.org/10.3390/ijms241512328
Chicago
Chi Zhang, Huihui Shao, Zunsheng Han, Bo Liu, Jing Feng, Jie Zhang, Wenxuan Zhang, Kun Zhang, Qingyun Yang, and Song Wu. 2023. “Development and In Vitro–In Vivo Correlation Evaluation of IMM-H014 Extended-Release Tablets for the Treatment of Fatty Liver Disease.” International Journal of Molecular Sciences 24 (15): 12328. doi:10.3390/ijms241512328.